Dr. Reddy\'s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market | Business Wire

Dr. Reddy\'s Laboratories Announces the Launch of Hydroxychloroquine Sulfate Tablets, USP in the U.S. Market | Business Wire: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announce